Conclusion of non-exclusive discount agreements pursuant to § 130 a para. 8 SGB V with the active ingredient budesonide in the dosage form HKM
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Budesonid in der Darreichungsform HKM
Germany
Contract
BuyerGWQ ServicePlus AG
TypeSupplies
Estimated valuevalue not published
Published3 February 2026
CategoryMedical equipment & pharma · CPV 33000000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Hexal AG · Holzkirchen | 67 | 2011–2026 |
| Aristo Pharma GmbH · Berlin | 54 | 2011–2026 |
| kohlpharma GmbH · Merzig | 54 | 2016–2023 |
| neuraxpharm Arzneimittel GmbH · Langenfeld | 49 | 2011–2026 |
| ratiopharm GmbH | 48 | 2015–2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
2019189
2020253
2021286
2022383
2023428
2024391
202512
2025354
2026165
Who knows the rhythm prepares instead of reacting.
263
days until the deadline — Monday 10 May at 06:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →